BioCardia, Inc. (BCDA) Current Ratio
- Current ratio · latest quarter: Value 2.09×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 2.09× | Current assets / current liabilities. $4.30M ÷ $2.06M ≈ 2.09× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 4.30M USD | Assets, Current |
| Current obligations | 2.06M USD | Liabilities, Current |
| Cash and equivalents | 4.12M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 30.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | 541.00K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.30M | $2.06M | $4.12M | (m) | $30.00K | (m) | $541.00K | (m) | 2.09× |
| 2026-03-31 | $1.14M | $2.78M | $951.00K | (m) | $20.00K | (m) | $820.00K | (m) | 0.41× |
| 2025-12-31 | $2.73M | $2.43M | $2.50M | (m) | $20.00K | (m) | $641.00K | (m) | 1.12× |
| 2025-09-30 | $5.37M | $3.31M | $5.29M | (m) | (m) | (m) | $1.08M | (m) | 1.62× |
| 2025-06-30 | $1.20M | $3.64M | $980.00K | (m) | $10.00K | (m) | $1.23M | (m) | 0.33× |
| 2025-03-31 | $1.17M | $3.23M | $949.00K | (m) | (m) | (m) | $818.00K | (m) | 0.36× |
| 2024-12-31 | $2.62M | $2.32M | $2.37M | (m) | $0.00 | (m) | $385.00K | (m) | 1.13× |
| 2024-09-30 | $5.06M | $2.84M | $4.93M | (m) | $10.00K | (m) | $569.00K | (m) | 1.78× |
| 2024-06-30 | $1.57M | $4.07M | $1.42M | (m) | $10.00K | (m) | $1.45M | (m) | 0.39× |
| 2024-03-31 | $1.26M | $4.07M | $949.00K | (m) | $58.00K | (m) | $1.03M | (m) | 0.31× |
| 2023-12-31 | $1.46M | $3.61M | $1.10M | (m) | $63.00K | (m) | $890.00K | (m) | 0.40× |
| 2023-09-30 | $2.12M | $3.33M | $1.83M | (m) | $104.00K | (m) | $507.00K | (m) | 0.64× |
| 2023-06-30 | $4.65M | $3.62M | $4.30M | (m) | $115.00K | (m) | $686.00K | (m) | 1.29× |
| 2023-03-31 | $5.29M | $4.00M | $4.86M | (m) | $153.00K | (m) | $861.00K | (m) | 1.32× |
| 2022-12-31 | $7.86M | $3.58M | $7.36M | (m) | $201.00K | (m) | $683.00K | (m) | 2.19× |
| 2022-09-30 | $7.15M | $3.68M | $6.67M | (m) | $300.00K | (m) | $887.00K | (m) | 1.94× |
| 2022-06-30 | $9.15M | $3.05M | $8.61M | (m) | $211.00K | (m) | $999.00K | (m) | 3.00× |
| 2022-03-31 | $10.66M | $3.91M | $9.93M | (m) | $326.00K | (m) | $764.00K | (m) | 2.72× |
| 2021-12-31 | $13.48M | $3.71M | $12.87M | (m) | $147.00K | (m) | $507.00K | (m) | 3.63× |
| 2020-12-31 | $22.66M | $4.25M | $21.41M | (m) | $232.00K | (m) | $746.00K | (m) | 5.33× |
| 2020-09-30 | $8.59M | $4.32M | $7.39M | (m) | $304.00K | (m) | $1.21M | (m) | 1.99× |
| 2020-06-30 | $12.10M | $4.55M | $11.09M | (m) | $214.00K | (m) | $1.52M | (m) | 2.66× |
| 2020-03-31 | $3.22M | $4.51M | $2.59M | (m) | $179.00K | (m) | $1.11M | (m) | 0.71× |
| 2019-12-31 | $6.38M | $4.00M | $5.58M | (m) | $147.00K | $4.00K | $914.00K | (m) | 1.59× |
| 2019-09-30 | $9.24M | $4.04M | $8.91M | (m) | $103.00K | $45.00K | $1.11M | (m) | 2.28× |
| 2019-06-30 | $1.15M | $4.07M | $517.00K | (m) | $204.00K | $5.00K | $1.63M | (m) | 0.28× |
| 2019-03-31 | $3.53M | $3.32M | $2.84M | (m) | $287.00K | $118.00K | $1.14M | (m) | 1.06× |
| 2018-12-31 | $6.22M | $2.55M | $5.36M | (m) | $274.00K | $141.00K | $743.00K | (m) | 2.44× |
| 2018-09-30 | $5.35M | $2.53M | $4.82M | (m) | $170.00K | $134.00K | $1.10M | (m) | 2.11× |
| 2018-06-30 | $7.44M | $1.82M | $6.83M | (m) | $191.00K | $136.00K | $505.00K | (m) | 4.09× |
| 2018-03-31 | $10.21M | $2.12M | $9.65M | (m) | $127.00K | $148.00K | $738.00K | (m) | 4.81× |
| 2017-12-31 | $13.31M | $2.33M | $12.69M | (m) | $95.00K | $191.00K | $902.00K | (m) | 5.71× |
| 2017-09-30 | $15.64M | $2.00M | $13.33M | (m) | $90.00K | $240.00K | $447.00K | (m) | 7.82× |
| 2017-06-30 | $17.52M | $1.61M | $15.11M | (m) | $142.00K | $193.00K | $590.00K | (m) | 10.90× |
| 2017-03-31 | $19.55M | $1.37M | $19.03M | (m) | $121.00K | $144.00K | $291.00K | (m) | 14.29× |
| 2016-12-31 | $21.92M | $1.44M | $21.35M | (m) | $74.00K | $135.00K | $525.00K | (m) | 15.18× |
| 2015-12-31 | $4.67M | $8.30M | $3.56M | (m) | $107.00K | $759.00K | $542.00K | (m) | 0.56× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |